FDA to review Champix side effects

The US Food and Drugs Administration (FDA) is to review the safety of smoking cessation drug varenicline (Champix) following reports of suicidal, aggressive and erratic behaviour.

Some of these reports have come from the manufacturer of the drug, Pfizer, and others from the media and the internet, the regulator said.

There have also been reports of drowsiness, to the point of affecting the ability to drive, associated with the use of Champix.

A Pfizer UK spokesperson said that there is no scientific evidence establishing a causal relationship between varenicline and the post-marketing report events, and the role of Champix, marketed as Chantix in the US, is still unknown.

The agency has now asked Pfizer for any additional cases of side-effects that it is aware of and is currently reviewing the data.

The FDA recommends that GPs monitor patients taking Champix for behaviour and mood changes.

The Pfizer spokesperson said it was too early to speculate on any potential impact the review would have on the marketing of Champix in the UK but said the pharmaceutical manufacturer was in close contact with the European Medicines Evaluation Agency (EMEA) regarding the FDA communication.

'Pfizer is assessing the potential impact on the European product information and will continue to collaborate with the EMEA on any further developments,' said Pfizer in a statement.

Champix was licensed by the European Medicines Agency (EMA) in September 2006 and was made available on the NHS.


Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Just published

Kamila Hawthorne

GP crisis could force one in four practices to close, says RCGP

Unmanageable pressure could force more than a quarter of GP practices to close, polling...

COVID-19 vaccine in pregnancy

Vaccination in pregnancy cuts COVID-19 risk for mother and baby

Vaccination against COVID-19 during pregnancy reduces the risk of infection and hospitalisation...

Child using smartphone

NICE backs digital CBT games for children with anxiety or low mood

GPs could prescribe CBT-based digital games, videos and quizzes for children and...

GP surgery sign

GP pressure to continue as experts warn NHS backlog will remain through 2023

General practice faces continuing heavy pressure after experts warned that the record...

Close-up of a man loading a shotgun

BMA updates GP firearms guidance as digital marker goes live on EMIS

The BMA has updated its guidance for GPs on firearms licensing following the release...

Map pins

Severely underdoctored areas spread across nearly every NHS region

Severely underdoctored areas exist in nearly every NHS region across England, figures...